We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+7.91%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$13.3B
AUM Growth
+$802M
Cap. Flow
-$35.2M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.63%
Holding
2,246
New
164
Increased
893
Reduced
982
Closed
190

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 10.11%
3 Healthcare 10%
4 Consumer Discretionary 8.02%
5 Industrials 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YUMC icon
1826
Yum China
YUMC
$16.4B
$300K ﹤0.01%
6,254
-1,112
-15% -$49.4K
BTT icon
1827
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
$299K ﹤0.01%
12,395
+3,506
+39% +$83.9K
CKH
1828
DELISTED
Seacor Holdings Inc.
CKH
$299K ﹤0.01%
6,934
-2,953
-30% -$129K
PATK icon
1829
Patrick Industries
PATK
$2.83B
$298K ﹤0.01%
8,535
-917
-10% -$29.8K
SHAK icon
1830
Shake Shack
SHAK
$2.63B
$298K ﹤0.01%
4,996
-872
-15% -$62.7K
TD icon
1831
Toronto Dominion Bank
TD
$198B
$298K ﹤0.01%
5,312
-2,467
-32% -$140K
JDD
1832
DELISTED
Nuveen Diversified Dividend and Income Fund
JDD
$298K ﹤0.01%
27,323
+7,779
+40% +$84.6K
AMWD
1833
DELISTED
American Woodmark
AMWD
$297K ﹤0.01%
2,840
+385
+16% +$38.7K
RY icon
1834
Royal Bank of Canada
RY
$291B
$297K ﹤0.01%
3,755
-9,525
-72% -$767K
CBT icon
1835
Cabot Corp
CBT
$4.15B
$296K ﹤0.01%
6,229
-2,922
-32% -$136K
BCX icon
1836
BlackRock Resources & Commodities Strategy Trust
BCX
$910M
$295K ﹤0.01%
36,518
-29,788
-45% -$227K
THC icon
1837
Tenet Healthcare
THC
$20.4B
$294K ﹤0.01%
+7,726
New +$231K
ZEUS
1838
DELISTED
Olympic Steel
ZEUS
$294K ﹤0.01%
16,411
-12,487
-43% -$198K
BNS icon
1839
Scotiabank
BNS
$107B
$293K ﹤0.01%
5,189
+1,023
+25% +$58.1K
ARCH
1840
DELISTED
Arch Resources, Inc.
ARCH
$293K ﹤0.01%
4,085
-2,890
-41% -$221K
FHI icon
1841
Federated Hermes
FHI
$4.8B
$292K ﹤0.01%
8,960
+195
+2% +$6.37K
DBI icon
1842
Designer Brands
DBI
$337M
$291K ﹤0.01%
18,485
+7,509
+68% +$124K
EZPW icon
1843
Ezcorp Inc
EZPW
$1.91B
$291K ﹤0.01%
42,665
+6,185
+17% +$35.5K
ICHR icon
1844
Ichor Holdings
ICHR
$2.47B
$291K ﹤0.01%
8,740
-1,807
-17% -$53.9K
AEO icon
1845
American Eagle Outfitters
AEO
$3.03B
$288K ﹤0.01%
+19,605
New +$299K
CS
1846
DELISTED
Credit Suisse Group
CS
$288K ﹤0.01%
21,389
+3,032
+17% +$38.8K
MNDT
1847
DELISTED
Mandiant, Inc. Common Stock
MNDT
$288K ﹤0.01%
17,416
-16,482
-49% -$264K
ACH
1848
Accendra Health
ACH
$224M
$287K ﹤0.01%
55,553
-52,329
-49% -$336K
PDT
1849
John Hancock Premium Dividend Fund
PDT
$632M
$287K ﹤0.01%
15,975
-10,468
-40% -$183K
BMO icon
1850
Bank of Montreal
BMO
$126B
$285K ﹤0.01%
3,679
+511
+16% +$38.5K

Similar funds

Guggenheim Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Guggenheim Capital held 2,246 positions worth $13.3B, up 6.4% from $12.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Guggenheim Capital's Q4 2019 filing shows 164 new, 893 increased, 982 reduced and 190 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 296,002 shares worth $95.7M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $90.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q4 2019 buy was iShares Core S&P 500 ETF: 296,002 shares worth $95.7M.
  • Guggenheim Capital added most to iShares Core US Aggregate Bond ETF in Q4 2019, an estimated $251M increase.
  • Guggenheim Capital's biggest Q4 2019 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $90.9M.
  • Guggenheim Capital fully exited Celgene Corp in Q4 2019, selling an estimated $33.4M.
  • Guggenheim Capital's ten largest holdings make up 13% of its $13.3B portfolio in Q4 2019.
  • Guggenheim Capital opened 164 new positions and closed 190 in Q4 2019.
  • Guggenheim Capital's portfolio value rose 6.4% quarter-over-quarter to $13.3B.

Based on Guggenheim Capital's 13F filing for Q4 2019, filed 14 Feb 2020.